FDA Warns of Link Between Fosamprenavir and Myocardial Infarction

Links shared publicly online about this topic

FDA: Link between fosamprenavir and MI, dyslipidemia

theheart.org — “Fosamprenavir calcium is associated with an increased risk of MI and dyslipidemia in HIV-infected adults, according to the FDA.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on December 8, 2009 at 6:11 pm By:

theheartorg Shelley Wood Cardiology

FDA warning: Increased MI, dyslipidemia with fosamprenavir http://bit.ly/5UVUcD #heartwire

2 years ago...

FDA Alert: Lexiva (fosamprenavir calcium) - Dear Healthcare Professional Letter

drugs.com — “FDA Alert: Lexiva (fosamprenavir calcium) - Dear Healthcare Professional LetterView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on December 4, 2009 at 7:44 pm By:

drugscom Drugs.com Health Site

FDA Alert - GlaxoSmithKline and FDA Inform Healthcare Professionals of New Warnings for Lexiva (fosamprenavir) - http://bit.ly/8j4QC2

2 years ago...

FDA warns of potential cardiovascular risk with Lexiva in HIV-infected patients - MPR

empr.com — “The FDA and GlaxoSmithKline have notified healthcare professionals of a potential association between Lexiva (fosamprenavir calcium) and myocardial infarction and dyslipidemia in HIV-infected adults.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on December 3, 2009 at 10:09 pm By:

eMPR MPR Medical Publisher

MPR News: FDA warns of potential cardiovascular risk with Lexiva in HIV-infected patients: The FDA and GlaxoSmithKl... http://bit.ly/6eyGj4

2 years ago...

FDA to parents: Don't toss ADHD drugs yet - Kids and parenting- msnbc.com

msnbc.msn.com — “The FDA is urging parents to keep their children on attention deficit drugs like Ritalin and Adderall, despite new evidence that the stimulants can increase the risk of sudden death.View full resource at msnbc.msn.com

  • View Related
  • Share

Most Recently Shared on June 15, 2009 at 5:16 pm By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • theheartorg

    Shelley Wood

    Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4

    View Profile

  • drugscom

    Drugs.com

    Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.

    View Profile

  • eMPR

    MPR

    eMPR.com provides up-to-date, concise drug information at the point-of-care.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390